|
Tocotrienols group (n = 30)
|
Changes at completion of the study
|
|---|
|
Baseline
|
Negative
|
Mild
|
Moderate
|
Severe
|
|---|
|
Mild (n = 22)
|
13/22
|
9/22
|
0/22
|
0/22
|
|
73.3%
|
59.1%
|
40.9%
|
0.0%
|
0.0%
|
|
Moderate (n = 6)
|
2/6
|
4/6
|
0/6
|
0/6
|
|
20.0%
|
33.3%
|
66.7%
|
0.0%
|
0.0%
|
|
Severe (n = 2)
|
0/2
|
1/2
|
0/2
|
1/2
|
|
6.7%
|
0.0%
|
50.0%
|
0.0%
|
50.0%
|
|
TOTAL
|
15/30
|
14/30
|
0/30
|
1/30
|
| |
50.0%
|
46.7%
|
0.0%
|
3.3%
|
|
Placebo group (n = 34)
|
Changes at completion of the study
|
|
Baseline
|
Negative
|
Mild
|
Moderate
|
Severe
|
|
Mild (n = 27)
|
8/27
|
17/27
|
2/27
|
0/27
|
|
79.4%
|
29.6%
|
63.0
|
7.4%
|
0.0%
|
|
Moderate (n = 6)
|
0/6
|
5/6
|
1/6
|
0/6
|
|
17.6%
|
0.0%
|
83.3%
|
16.7%
|
0.0%
|
|
Severe (n = 1)
|
0/1
|
0/1
|
1/1
|
0/1
|
|
2.9%
|
0.0%
|
0.0%
|
100.0%
|
0.0%
|
|
TOTAL
|
8/34
|
22/34
|
4/34
|
0/34
|
| |
23.5%
|
64.7%
|
11.8%
|
0.0%
|
|
Tocotrienols vs Placebo
|
Chi Sq = 4.851
|
P = 0.014
| | |
- Details of the clinical evaluation of subjects at baseline and relative changes after 1 year of treatment.
- [Helmert-Pearson’s Chi Square; Numbers’09, GraphPad].
